Effectiveness of a combined paced-breathing and mobile app–based mindfulness intervention for chronic migraine: A randomized controlled trial
Background: Mindfulness has been proposed as a non-pharmacological strategy for chronic migraine management.
Objective: This study evaluated the effectiveness of a combined paced-breathing and mobile app–based mindfulness intervention in adults with chronic migraine.
Methods: A randomized controlled trial was conducted in adults with chronic migraine. Forty participants were randomized, and 38 were included in the final analyses. The intervention group was assigned to a 12-week combined intervention consisting of paced breathing followed by a mobile app–based mindfulness intervention delivered through the Petit BamBou® app; the control group remained on a waitlist and continued usual care. The primary outcome was migraine days per month. Secondary outcomes included migraine episode pain intensity and duration, headache-related quality of life (Headache Impact Test-6), anxiety sensitivity (Anxiety Sensitivity Index-3), kinesiophobia (Tampa Scale for Kinesiophobia-11), and sleep quality (Athens Insomnia Scale). Between-group differences at post-intervention were evaluated using analysis of covariance, adjusting each outcome for its corresponding baseline value.
Results: No statistically significant baseline-adjusted between-group differences were observed for migraine frequency or for any secondary outcome. For the primary outcome, the adjusted mean difference between the control and intervention groups was −3.07 migraine days per month (95% CI, −8.00 to 1.86; F(1, 35) = 1.599; p = 0.214; ηp2 = 0.044). Effect sizes were small for all outcomes.
Conclusion: A 12-week combined paced-breathing and mobile app–based mindfulness intervention was not superior to waitlist usual care for reducing migraine frequency or improving the evaluated clinical and psychological outcomes. These findings should be interpreted cautiously because of the small sample size, the marked baseline imbalance in migraine frequency, the use of a waitlist control group, and the absence of objective adherence monitoring. Future trials should include larger samples, active control conditions, objective measures of engagement, and longer follow-up periods. (Australian New Zealand Clinical Trials Registry, ACTRN12624000611527 [prospectively registered on May 10, 2024]).
- Zebenholzer K, Andree C, Lechner A, et al. Prevalence, management and burden of episodic and chronic headaches—a cross-sectional multicentre study in eight Austrian headache centres. J Headache Pain. 2015;16:46. doi: 10.1186/s10194-015-0531-7
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. doi: 10.1177/0333102417738202
- Belvís R, Irimia P, González N, et al. Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment. Med Clin (Barc). 2024;163(4):208.e1-208.e10. doi: 10.1016/j.medcli.2024.02.006
- Agostoni EC, Barbanti P, Calabresi P, et al. Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J Headache Pain. 2019;20(1):92. doi: 10.1186/s10194-019-1038-4
- Ferrari A, Baraldi C, Sternieri E. Medication overuse and chronic migraine: a critical review according to clinical pharmacology. Expert Opin Drug Metab Toxicol. 2015;11(7):1127-1144. doi: 10.1517/17425255.2015.1043265
- Diener HC, Donoghue S, Gaul C, et al. Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application. Trials. 2022;23(1):382. doi: 10.1186/s13063-022-06329-2
- Han X, Yu S. Non-pharmacological treatment for chronic migraine. Curr Pain Headache Rep. 2023;27(11):663-672. doi: 10.1007/s11916-023-01162-x
- Cebrino J, Portero de la Cruz S. Prevalence and associated factors of depression among adults suffering from migraine in Spain. Brain Sci. 2023;13(12):1630. doi: 10.3390/brainsci13121630
- Fisher E, Law E, Dudeney J, Palermo TM, Stewart G, Eccleston C. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2018;9(9):CD003968. doi: 10.1002/14651858.CD003968.pub5
- Wells RE, O'Connell N, Pierce CR, et al. Effectiveness of mindfulness meditation vs headache education for adults with migraine: a randomized clinical trial. JAMA Intern Med. 2021;181(3):317-328. doi: 10.1001/jamainternmed.2020.7090
- Goyal M, Haythornthwaite JA, Jain S, et al. Intensive mindfulness meditation reduces frequency and burden of migraine: an unblinded single-arm trial. Mindfulness (N Y). 2023;14(2):406-417. doi: 10.1007/s12671-023-02073-z
- Pei JH, Ma T, Nan RL, et al. Mindfulness-based cognitive therapy for treating chronic pain: a systematic review and meta-analysis. Psychol Health Med. 2021;26(3):333-346. doi: 10.1080/13548506.2020.1849746
- Cuenca-Martínez F, Suso-Martí L, Herranz-Gómez A, et al. Effectiveness of telematic behavioral techniques to manage anxiety, stress and depressive symptoms in patients with chronic musculoskeletal pain: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(6):3231. doi: 10.3390/ijerph19063231
- Hearn JH, Cotter I, Finlay KA. Efficacy of internet-delivered mindfulness for improving depression in caregivers of people with spinal cord injuries and chronic neuropathic pain: a randomized controlled feasibility trial. Arch Phys Med Rehabil. 2019;100(1):17-25. doi: 10.1016/j.apmr.2018.08.182
- Seng EK, Hill J, Reeder AK, et al. Feasibility, acceptability, and fidelity of remote-delivered abbreviated mindfulness-based cognitive therapy interventions for patients with migraine and depressive symptoms. Headache. 2025;65(4):545-557. doi: 10.1111/head.14857
- Bakhshani NM, Amirani A, Amirifard H, Shahrakipoor M. The effectiveness of mindfulness-based stress reduction on perceived pain intensity and quality of life in patients with chronic headache. Glob J Health Sci. 2015;8(4):142-151. doi: 10.5539/gjhs.v8n4p142
- Khazraee H, Bakhtiari M, Kianimoghadam AS, Hajmanouchehri R. The effectiveness of mindful hypnotherapy on psychological inflexibility, pain acceptance, headache disability and intensity in females with chronic migraine headache: a randomized clinical trial. Life (Basel). 2023;13(1):131. doi: 10.3390/life13010131
- Rosenzweig S, Greeson JM, Reibel DK, Green JS, Jasser SA, Beasley D. Mindfulness-based stress reduction for chronic pain conditions: variation in treatment outcomes and role of home meditation practice. J Psychosom Res. 2010;68(1):29-36. doi: 10.1016/j.jpsychores.2009.03.010
- Minen M, George A, Lebowitz N, Katara A, Snyder I. Headache providers' perspectives of headache diaries in the era of increasing technology use: a qualitative study. Front Neurol. 2023;14:1270555. doi: 10.3389/fneur.2023.1270555
- Colorado-Martín Y, Pecos-Martín D, de Miguel-Hernando N, et al. Validation of the Spanish version of the Headache Impact Test (HIT-6) in patients with episodic migraine. Brain Behav. 2025;15(5):e70515. doi: 10.1002/brb3.70515
- Taylor S, Zvolensky MJ, Cox BJ, et al. Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3. Psychol Assess. 2007;19(2):176-188. doi: 10.1037/1040-3590.19.2.176
- Woby SR, Roach NK, Urmston M, Watson PJ. Psychometric properties of the TSK-11: a shortened version of the Tampa Scale for Kinesiophobia. Pain. 2005;117(1-2):137-144. doi: 10.1016/j.pain.2005.05.029
- Soldatos CR, Dikeos DG, Paparrigopoulos TJ. Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res. 2000;48(6):555-560. doi: 10.1016/S0022-3999(00)00095-7
- Hagströmer M, Oja P, Sjöström M. The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr. 2006;9(6):755-762. doi: 10.1079/PHN2005898
- Richardson JTE. Eta squared and partial eta squared as measures of effect size in educational research. Educ Res Rev. 2011;6(2):135-147. doi: 10.1016/j.edurev.2010.12.001
- Anheyer D, Leach MJ, Klose P, Dobos G, Cramer H. Mindfulness-based stress reduction for treating chronic headache: a systematic review and meta-analysis. Cephalalgia. 2019;39(4):544-555. doi: 10.1177/0333102418781795
- Wells RE, Burch R, Paulsen RH, Wayne PM, Houle TT, Loder E. Meditation for migraines: a pilot randomized controlled trial. Headache. 2014;54(9):1484-1495. doi: 10.1111/head.12420
- Simshäuser K, Lüking M, Kaube H, Schultz C, Schmidt S. Is mindfulness-based stress reduction a promising and feasible intervention for patients suffering from migraine? A randomized controlled pilot trial. Complement Med Res. 2020;27(1):19-30. doi: 10.1159/000501425
- Napadow V. The mindful migraine: does mindfulness-based stress reduction relieve episodic migraine? Pain. 2020;161(8):1685-1687. doi: 10.1097/j.pain.0000000000001859
- Linardon J, Fuller-Tyszkiewicz M. Attrition and adherence in smartphone-delivered interventions for mental health problems: a systematic and meta-analytic review. J Consult Clin Psychol. 2020;88(1):1-13. doi: 10.1037/ccp0000459
- Hernández-Rodríguez JC, García-Muñoz C, Ortiz-Álvarez J, Saigí-Rubió F, Conejo-Mir J, Pereyra-Rodriguez JJ. Dropout rate in digital health interventions for the prevention of skin cancer: systematic review, meta-analysis, and metaregression. J Med Internet Res. 2022;24(12):e42397. doi: 10.2196/42397
